Report: U.S. Anti-Doping Agency Will Supervise Drug Testing for Floyd Mayweather, Manny Pacquiao

In another move that will please boxing fans, the May 2 bout between Floyd Mayweather and Manny Pacquiao will feature rigorous drug testing administered by the U.S. Anti-Doping Agency (USADA).

A report on Friday from the L.A. Times revealed that both competitors will be subjected to random in- and out-of-competition blood and/or urine tests leading up to the pay-per-view, which would then result in a four-year ban if either fighter tested positive.

Both Mayweather and Pacquiao have also already agreed to the rigid standards laid out by the World Anti-Doping Agency (WADA) code. The fact that both signed on for this leading into the fight may signify that the pair laid this out in their original bout agreement. Pacquiao infamously refused to undergo blood tests during negotiations for the fight in 2009.

Most recently, Pacquiao underwent random drug testing conducted by the Voluntary Anti-Doping Association (VADA) during the leadup to his November fight against Chris Algieri.

Mayweather versus Pacquiao will emanate from the MGM Grand Garden Arena on May 2. Tickets for the event will range from $1500-$7500 and the pay-per-view telecast will reportedly cost less than $100.